Evidence map›Paper›PMID 32126207›Full record

ArticleMolecular cell2020

FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster.

Hui Wang, Hui Shi, Malini Rajan, Elizabeth R Canarie, Seoyeon Hong, Daniele Simoneschi, Michele Pagano, Matthew F Bush, Stefan Stoll, Elizabeth A Leibold and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 192 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Iron Dysregulation and Vascular Diseases: A Contemporary Review.Journal of the American Heart Association · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Hui WangDepartment of Pharmacology, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Hui ShiDepartment of Pharmacology, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Malini RajanDivision of Hematology and Hematologic Malignancies and Molecular Medicine Program, University of Utah, Salt Lake City, UT 84112, USA.
Elizabeth R CanarieDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.
Seoyeon HongDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.
Daniele SimoneschiDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; NYU Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.
Michele PaganoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; NYU Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, New York University School of Medicine, New York, NY 10016, USA.
Matthew F BushDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.
Stefan StollDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.
Elizabeth A LeiboldDivision of Hematology and Hematologic Malignancies and Molecular Medicine Program, University of Utah, Salt Lake City, UT 84112, USA.
Ning ZhengDepartment of Pharmacology, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA. Electronic address: nzheng@uw.edu.
Howard Hughes Medical Institute · USUniversity of Washington · USUniversity of Utah · USNew York University · US

Funding

TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
Acquisition of a high resolution, high throughput cryo-electron microscopeS10OD023476 · OD · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M · 2017 to 2017
$2.0M
Iron in beta cell functionR01DK107712 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN · 2016 to 2019
$1.5M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK107712NIGMS NIH HHS R01 GM057587NIGMS NIH HHS T32 GM008268NIH HHS S10 OD023476
6 · The paper itself

Abstract

Cellular iron homeostasis is dominated by FBXL5-mediated degradation of iron regulatory protein 2 (IRP2), which is dependent on both iron and oxygen. However, how the physical interaction between FBXL5 and IRP2 is regulated remains elusive. Here, we show that the C-terminal substrate-binding domain of FBXL5 harbors a [2Fe2S] cluster in the oxidized state. A cryoelectron microscopy (cryo-EM) structure of the IRP2-FBXL5-SKP1 complex reveals that the cluster organizes the FBXL5 C-terminal loop responsible for recruiting IRP2. Interestingly, IRP2 binding to FBXL5 hinges on the oxidized state of the [2Fe2S] cluster maintained by ambient oxygen, which could explain hypoxia-induced IRP2 stabilization. Steric incompatibility also allows FBXL5 to physically dislodge IRP2 from iron-responsive element RNA to facilitate its turnover. Taken together, our studies have identified an iron-sulfur cluster within FBXL5, which promotes IRP2 polyubiquitination and degradation in response to both iron and oxygen concentrations.

Indexed as

Cell LineF-Box ProteinsHomeostasisHumansIronIron Regulatory Protein 2Iron-Sulfur ProteinsModels, MolecularOxygenProtein BindingProtein StabilityS-Phase Kinase-Associated ProteinsUbiquitin-Protein Ligase ComplexesF-Box ProteinsFBXL5 protein, humanIREB2 protein, humanIronIron Regulatory Protein 2Iron-Sulfur ProteinsOxygenSKP1 protein, humanS-Phase Kinase-Associated ProteinsUbiquitin-Protein Ligase Complexescryo-EMFBXL5iron homeostasisiron-sulfur clusterIRP2oxygen-responsive

Identifiers

PMID32126207
PMCPMC7159994
OpenAlexW3009717183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.